Results 61 to 70 of about 14,742 (226)

Plexiform neurofibroma of the submandibular gland in patient with von Recklinghausen's disease

Rare Tumors, 2011
Plexiform neurofibroma of the submandibular gland is an extremely rare tumor. Herein, we report a case of plexiform neurofibroma in a patient with a von Recklinghausen's disease (NF-1) who presented with a submandibular mass mimicking a submandibular ...
Hassan Al Bisher, Ravi Kant, Ahmed Aldamati, Aysha Ahmed Badar   +3 more
doaj   +1 more source

Atypical presentation of extraspinal neurofibroma presenting with acute-onset monoparesis and Horner's syndrome: Case report and review of literature

Journal of Craniovertebral Junction and Spine, 2019
The clinical presentation of spinal or extraspinal neurofibroma is radiculopathy or myelopathy, pain, and motor weakness. Extraspinal neurofibroma presenting with acute-onset monoparesis and Horner's syndrome is very rare. We report the case of a 55-year-
Lokesh S Nehete, Subhas K Konar, B N Nandeesh, Dhaval Shukla, B Indira Devi   +4 more
doaj   +1 more source

Neurofibroma solitario en pared abdominal en paciente sin neurofibromatosis: reporte de caso

, 2009
Introducción. Los neurofibromas solitarios son tumores benignos de carácter hereditario, que presentan variantes. Las manifestaciones clínicas cambian según su localización y, ocasionalmente, son similares a las de la neurofibromatosis.
Ludwing Flórez Salamanca, Juan Sebastián Barajas, Flórez Salamanca, Ludwing, Barajas, Juan Sebastián   +3 more
core   +1 more source

Diffuse neurofibroma of the chest and abdominal wall invading the diaphragm leads to diaphragmatic eventration: case report

BMC Surgery, 2021
Background Neurofibromatosis type 1 (NF1) is an autosomal dominant condition with a high rate of new mutation and variable expression. Diffuse neurofibroma of the epidermis invading deeper organs is rare.We report a case of diffuse subcutaneous ...
Xian-shuai Li, Shu-qian He, Xian-guo Chen   +2 more
doaj   +1 more source

Periodontal Disease and Salivary Gland Dysfunction in Neurofibromatosis Type 1: A Case–Control Study

Oral Diseases, EarlyView.
ABSTRACT Objectives Neurofibromatosis type 1 (NF1) presents with diverse systemic and oral manifestations. The aim of this study was to investigate the periodontal status and salivary alterations in NF1 individuals. Methods A total of 38 individuals with NF1 diagnostic criteria were compared with a control group paired by age and sex.
Eloá Borges Luna, Gustavo de Souza Vieira, Flávia Lima Kleinsorgen Motta, Ana Beatriz Oliveira Gambôa, Analúcia Rampazzo Xavier, Rafaela Elvira Rozza‐de‐Menezes, Karin Soares Cunha   +6 more
wiley   +1 more source

The 9th International RASopathies Symposium

American Journal of Medical Genetics Part A, Volume 200, Issue 8, Page 1934-1941, August 2026.
ABSTRACT The RASopathies are a group of congenital disorders with overlapping clinical manifestations that are caused by pathogenic germline or early somatic variants that result in the hyperactivation of the RAS/mitogen‐activated protein kinase (MAPK) signaling pathway.
Pau Castel, Lisa Schoyer, Beth Stronach, Raya Bogdanova, Anton M. Bennett, Jaishri Blakeley, Miriam Bornhorst, Tammy Bowers, Saskia M. Brachmann, Emma Burkitt‐Wright, Kathryn Chatfield, Alessandro De Luca, Khalil El‐Chammas, Abdul Elkadri, John E. Fortunato, Bruce D. Gelb, Anne Goriely, Karen Gripp, Kassidy Grover, Lindsay Homan, Kenneth A. Kern, Maija Kiuru, Charles (Chuck) Lawson, Yong‐Seok Lee, Frank McCormick, Gina Ney, Cristina Nuevo‐Tapioles, Sara Pardej, Elizabeth I. Pierpont, Julia Plank, Nancy Ratner, Katherine A. Rauen, J. Elliott Robinson, Les Rogers, Sarah E. Sheppard, Keir Shiels, David Stevenson, Dagmar Tiemens, Matthew Traylor, K. Nicole Weaver, Marielle Yohe, Tamar Green   +41 more
wiley   +1 more source

A 67‐year‐old man with a spinal extramedullary mass

Brain Pathology, EarlyView.
Marcella Callea, Francesco Costa, Rosina Paterra, Valeria Barresi   +3 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice. [PDF]

, 2019
Plexiform neurofibroma is a major contributor to morbidity in patients with neurofibromatosis type I (NF1). Macrophages and mast cells infiltrate neurofibroma, and data from mouse models implicate these leukocytes in neurofibroma development ...
Pundavela, Jay, Miller, Jacob, Chetal, Kashish, Jessen, Walter, Ratner, Nancy, Salomonis, Nathan, Wu, Jianqiang, Fletcher, Jonathan, Rizvi, Tilat, Dombi, Eva, Kim, Mi-Ok   +10 more
core   +1 more source

Neurofibroma of parotid [PDF]

BMJ Case Reports, 2011
Tumours of neurogenic origin are rare in parotid gland. The authors are presenting here a case of neurofibroma in a 40-year-male who presented with slow growing tumour in preauricular region of 1 year duration.
Veena, Maheshwari, Manoranjan, Varshney, Kiran, Alam, Roobina, Khan, Anshu, Jain, Kavita, Gaur, Arshad Hafeez, Khan   +6 more
openaire   +2 more sources